Prognostic Factors for Visual Outcomes 2-Years After Intravitreal Bevacizumab for Myopic Choroidal Neovascularization

Eye - United Kingdom
doi 10.1038/eye.2010.226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks

Archives of Ophthalmology
2007English

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization Associated With Pattern Dystrophy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Subfoveal Choroidal Thickness Changes After Intravitreal Bevacizumab Therapy for Central Serous Chorioretinopathy

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2016English

Visual Acuity Outcomes of Ranibizumab Treatment in Pathologic Myopic Eyes With Macular Retinoschisis and Choroidal Neovascularization

Retina
MedicineOphthalmology
2017English

Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks in a Non-Responder to Intravitreal Ranibizumab

International Medical Case Reports Journal
Medicine
2018English

Reply To: Effect of Axial Length on Myopic Choroidal Neovascularization

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Long-Term Results of Intravitreal Bevacizumab and Dexamethasone for the Treatment of Punctate Inner Choroidopathy Associated With Choroidal Neovascularization: A Case Series

SAGE Open Medical Case Reports
2018English

Suppression of Choroidal Neovascularization by Intravitreal Injection of Liposomal SU5416

Archives of Ophthalmology
2011English

Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy